Ukrainian President Volodymyr Zelenskyy has made it clear—he is not interested in talks with Russian officials, except for Vladimir Putin himself, and only under strict terms. "I will not meet with Russians. I will meet only one Russian—Putin. But only after we have a common plan with Trump and Europe. Then, we will sit down with Putin and end the war. Only in this case am I ready to meet him." This comes after U.S. President Donald Trump suggested holding Ukraine-Russia talks in Saudi Arabia.

Ukrainian President Volodymyr Zelenskyy has made it clear—he is not interested in talks with Russian officials, except for Vladimir Putin himself, and only under strict terms. "I will not meet with Russians. I will meet only one Russian—Putin. But only after we have a common plan with Trump and Europe. Then, we will sit down with Putin and end the war. Only in this case am I ready to meet him." This comes after U.S. President Donald Trump suggested holding Ukraine-Russia talks in Saudi Arabia.

                Christmas.

In a few months it will be Christmas. Today, I am suffering from Cancer and may not be here for Christmas and so I am leaving you this small poem...  

                                CHRISTMAS.

GENTLE FANTASIES AND SWEET LIES BATHED IN BEAUTIFUL MUSIC FROM DECADES PAST, ALWAYS WAS AND ALWAYS WILL BE CHRISTMAS!

HAVE A HAPPY HOLIDAY SEASON!

NO MATTER WHAT RACE OR RELIGION OR REASON...

HAVE A SUNSHINE DAY AND A STAR FILLED NIGHT!

AND MAY THE MOON SHINE BRIGHT ON YOUR LOVE, TONIGHT...

HAVE A HAPPY HOLIDAY SEASON!

NO MATTER WHAT RACE OR RHYME, RELIGION OR REASON.

MERRY CHRISTMAS!

      POET: JOSEPH NELSON RAGLIONE. AUGUST 11, 2025.                            

 GENTLE READERS:

 FOR THOSE OF YOU INUNDATED BY UNWANTED ADVERTISING, TRY BLOGGER.COM. IT WILL GIVE YOU A CHOICE. A BLOG WIHOUT ADVERTISING AND ZERO MONEY FROM ADVERTING OR A BLOG SO FILLED WITH ADVERTISING YOU QUICKLY WANT TO SEND YOUR TELEPHONE OR COMPUTER FOR A LONG SWIM IN DEEP WATER.

 I CHOSE ZERO ADVERTING AND MY BLOG IS GREAT! IT WILL EVEN PROVIDE ME WITH NEWS FROM AROUND THE WORLD WITHOUT ADVERTISING, IF I LOG IN USING MY OWN IDENTIFICATION. YOU CAN DO THE SAME BY CREATING YOUR OWN BLOG BUT BE ADVISED... CHOOSE WISELY!

YOU FRIENDLY HUMANITARIAN.

N.J.R.

The fight for my life!

 Hello Gentle People!

 I won't recover from Cancer but I can give it a hell of a fight, for as long as possible!

If you don't know me by now, here is a reminder. 

I registered the WORLD FRIENDLY HUMANITARIAN PEACE AND ECOLOGY MOVEMENT on the  Google web space, and because I did that, my web email box is now crowded with non profit organizations all asking for money!

The word donate has become a curse! Too many people use it to ask me for money! I am not a philanthropist and I don't have that much money! What I do have left I am keeping to help me survive the next few months. 

After my departure from this life, I will leave something behind for legal non profits, but not before! 

Thanks for understanding!

Yours in friendship and good faith.

Nelson Joseph Raglione.

Out dated school books.

 Gentle Canadians.

   Some school books in Canada are out dated. How out-dated? When a book is printed Ten years in the past, it is outdated! Check your children's school books for the print date. Today's information is evolving  fast with super computers and even faster with the help of artificial intelligence. Are outdated school books still viable? Are pocket telephones now acting as teachers and professors? To answer these questions I am going to ask my arificially intelligent computer.

Buy for now!   N. J.R.

If you don't know for whom to vote, vote for love, it's a winner!

 Gentle People:                                                                                        Sunday, April 13, 2025.

  The environment is being placed on the back burner during this Canadian election. Global warming, however, is a fact that will not be denied!

1.  Fact. A forest fire destoyed a complete town in California and wiped out a million Trees and thousands of small animals.

2.  Fact: A hurricane destroyed lives and buildings in Florida, U.S.A..

3.  Fact: Floods ravaged Portugal and Spain and Asia as the Oceans become warmer.

4.  Fact: Pollution in the air we breath is slowly poisoning millions of people.

5.  Fact: Pollution is created when we destroy our Oxygen creating forests in order to create thousands of houses and condomiums and millions of paper products.

6.  Fact: Our so called "Natural Resources" perpetuate global warming and our "Fossil Fuels" are polluting us and the rest of the world.

5.  Question: Which politician in Canada wants to exploit our "natural resources" for profit?

6. Vote according to your conscience. Vote for: clean air, clean water, and clean food! Stop the Oil Pipeline once and for all.

Welcome to our investor page

Biopharmaceutical New Technologies, or BioNTech, is a global, fully integrated next-generation immunotherapy company pioneering novel therapies for cancer, infectious diseases and other serious diseases. We exploit a wide array of computational discovery and therapeutic drug platforms for the rapid development of novel biopharmaceuticals. We have built a broad toolkit across multiple technology platforms, including a diverse range of potentially first-in-class therapeutic approaches. This includes mRNA vaccines, cell and gene therapies, targeted antibodies, small molecule immunomodulators, ribologicals, and next-generation immunomodulators. Our approach has created a robust and diversified product pipeline across infectious disease and oncology, including our first commercial product, COMIRNATY, our COVID-19 vaccine. COMIRNATY is the first ever approved mRNA drug product. Our clinical pipeline includes more than 25 product candidates in oncology and infectious diseases. BioNTech has established a broad set of relationships with multiple global pharmaceutical collaborators, including Genmab, Genentech, a member of the Roche Group, Regeneron, Genevant, Fosun Pharma, and Pfizer. We believe we are well-positioned to develop and commercialize the next generation of immunotherapies with the potential to transform treatment paradigms for many severe diseases. to our investor page

Biopharmaceutical New Technologies, or BioNTech, is a global, fully integrated next-generation immunotherapy company pioneering novel therapies for cancer, infectious diseases and other serious diseases. We exploit a wide array of computational discovery and therapeutic drug platforms for the rapid development of novel biopharmaceuticals. We have built a broad toolkit across multiple technology platforms, including a diverse range of potentially first-in-class therapeutic approaches. This includes mRNA vaccines, cell and gene therapies, targeted antibodies, small molecule immunomodulators, ribologicals, and next-generation immunomodulators. Our approach has created a robust and diversified product pipeline across infectious disease and oncology, including our first commercial product, COMIRNATY, our COVID-19 vaccine. COMIRNATY is the first ever approved mRNA drug product. Our clinical pipeline includes more than 25 product candidates in oncology and infectious diseases. BioNTech has established a broad set of relationships with multiple global pharmaceutical collaborators, including Genmab, Genentech, a member of the Roche Group, Regeneron, Genevant, Fosun Pharma, and Pfizer. We believe we are well-positioned to develop and commercialize the next generation of immunotherapies with the potential to transform treatment paradigms for many severe diseases.